logo

DBD

Diebold Nixdorf·NYSE
--
--(--)
--
--(--)
5.65 / 10
Netural

DBD's fundamental standing is mixed, scoring 5.7/10. Constructive aspects: Net income-Revenue (-0.9965) and Profit-MV (0.0280) earn 3 and 2 points respectively, indicating relative strength in earnings quality and profit scale. However, PCF (25.7928) and ROE (0.0423) rank in lower quartiles (0 points), signaling cash-flow inefficiency and weak equity returns. The low PB (0.5763) offers valuation support, yet elevated PE (51.46) suggests limited earnings leverage. Overall, the balance of positives and negatives yields a neutral fundamental rating.

Fundamental(5.65)SentimentTechnical

Analysis Checks(5/10)

PB
Value0.58
Score2/3
Weight11.52%
1M Return12.52%
PCF
Value25.79
Score0/3
Weight3.46%
1M Return3.48%
EV/EBIT
Value36.25
Score0/3
Weight2.74%
1M Return3.24%
PE
Value51.46
Score0/3
Weight3.46%
1M Return3.96%
Profit-MV
Value0.03
Score2/3
Weight9.13%
1M Return10.29%
Net income-Revenue
Value-1.00
Score3/3
Weight11.13%
1M Return11.87%
PB-ROE
Value-0.46
Score2/3
Weight11.52%
1M Return12.52%
ROE
Value0.04
Score0/3
Weight2.80%
1M Return3.07%
Asset-MV
Value-0.43
Score3/3
Weight42.67%
1M Return34.57%
Cash-MV
Value0.14
Score0/3
Weight1.58%
1M Return1.89%
Is DBD fundamentally strong?
  • DBD scores 5.65/10 on fundamentals and holds a Fair valuation at present. Backed by its 4.39% ROE, 1.45% net margin, -203.93 P/E ratio, 2.36 P/B ratio, and 13500.00% earnings growth, these metrics solidify its Netural investment rating.